Analysis of DNA Methylation Gene Mutations and Clinical Features in Patients with Myeloproliferative Neoplasm.
10.19746/j.cnki.issn.1009-2137.2022.02.033
- Author:
Zi-Qing WANG
1
;
Yu-Jin LI
2
;
De-Hao WANG
1
;
Er-Peng YANG
2
;
Yu-Meng LI
3
;
Ji-Cong NIU
2
;
Ming-Qian SUN
4
;
Zhuo CHEN
3
;
Wei-Yi LIU
5
;
Xiao-Mei HU
6
Author Information
1. Graduate School of Beijing University of Chinese Medicine, Beijing 100029, China.
2. Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091.
3. Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091,China.
4. Institute of Basic Medicine Sciences of Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091， China.
5. Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091,China,E-mail：liuweiyi0530@hotmail.com.
6. Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091,China,E-mail：huxiaomei_2@163.com.
- Publication Type:Journal Article
- Keywords:
DNA methylation gene;
clinical features;
myeloproliferative neoplasm;
next-generation sequencing technology
- MeSH:
Calreticulin/genetics*;
DNA Methylation;
Female;
Humans;
Janus Kinase 2/genetics*;
Mutation;
Myeloproliferative Disorders/genetics*;
Polycythemia Vera/genetics*
- From:
Journal of Experimental Hematology
2022;30(2):522-528
- CountryChina
- Language:Chinese
